Chevreau C - Search Results

1

Paronychia and pyogenic granuloma induced by new anticancer mTOR inhibitors.

Sibaud V, Dalenc F, Mourey L, Chevreau C. Sibaud V, et al. Among authors: chevreau c. Acta Derm Venereol. 2011 Sep;91(5):584-5. doi: 10.2340/00015555-1097. Acta Derm Venereol. 2011. PMID: 21667012 Free article. No abstract available.

2

Ototoxicity of high-dose carboplatin.

Chevreau C, Thomas F, Couteau C, Dalenc F, Mourey L, Chatelut E. Chevreau C, et al. J Clin Oncol. 2005 May 20;23(15):3649-50; author reply 3650-1. doi: 10.1200/JCO.2005.05.348. J Clin Oncol. 2005. PMID: 15908692 No abstract available.

3

[Cutaneous side effects associated with epidermal growth factor receptor and tyrosine kinase inhibitors].

Deslandres M, Sibaud V, Chevreau C, Delord JP. Deslandres M, et al. Among authors: chevreau c. Ann Dermatol Venereol. 2008 Jan;Spec No 1:16-24. doi: 10.1016/S0151-9638(08)70093-0. Ann Dermatol Venereol. 2008. PMID: 18342113 Review. French.

4

Sorafenib-induced eruptive melanocytic lesions.

Kong HH, Sibaud V, Chanco Turner ML, Fojo T, Hornyak TJ, Chevreau C. Kong HH, et al. Among authors: chevreau c. Arch Dermatol. 2008 Jun;144(6):820-2. doi: 10.1001/archderm.144.6.820. Arch Dermatol. 2008. PMID: 18559790 Free PMC article. No abstract available.

5

Sorafenib-induced hand-foot skin reaction: a Koebner phenomenon?

Sibaud V, Delord JP, Chevreau C. Sibaud V, et al. Among authors: chevreau c. Target Oncol. 2009 Dec;4(4):307-10. doi: 10.1007/s11523-009-0127-8. Epub 2009 Nov 7. Target Oncol. 2009. PMID: 19894099

6

HFS-14, a specific quality of life scale developed for patients suffering from hand-foot syndrome.

Sibaud V, Dalenc F, Chevreau C, Roché H, Delord JP, Mourey L, Lacaze JL, Rahhali N, Taïeb C. Sibaud V, et al. Among authors: chevreau c. Oncologist. 2011;16(10):1469-78. doi: 10.1634/theoncologist.2011-0033. Epub 2011 Sep 30. Oncologist. 2011. PMID: 21964002 Free PMC article.

7

[Dermatologic side effects induced by new angiogenesis inhibitors].

Sibaud V, Garrido-Stowhas I, Cottura E, Chevreau C. Sibaud V, et al. Among authors: chevreau c. Bull Cancer. 2011 Oct;98(10):1221-9. doi: 10.1684/bdc.2011.1457. Bull Cancer. 2011. PMID: 22001771 Review. French.

8

[Dermatologic adverse events of the new targeted anticancer therapies used in oncodermatology].

Sibaud V, Delord JP, Chevreau C, Gangloff D, Garrido-Stowhas I. Sibaud V, et al. Among authors: chevreau c. Ann Chir Plast Esthet. 2012 Apr;57(2):106-13. doi: 10.1016/j.anplas.2012.02.002. Epub 2012 Mar 15. Ann Chir Plast Esthet. 2012. PMID: 22425393 Review. French.

9

Geographic tongue induced by angiogenesis inhibitors.

Hubiche T, Valenza B, Chevreau C, Fricain JC, Del Giudice P, Sibaud V. Hubiche T, et al. Among authors: chevreau c. Oncologist. 2013;18(4):e16-7. doi: 10.1634/theoncologist.2012-0320. Epub 2013 Apr 10. Oncologist. 2013. PMID: 23576484 Free PMC article. No abstract available.

10

[Radiosensitization induced by vemurafenib].

Ducassou A, David I, Delannes M, Chevreau C, Sibaud V. Ducassou A, et al. Among authors: chevreau c. Cancer Radiother. 2013 Jul-Aug;17(4):304-7. doi: 10.1016/j.canrad.2013.04.004. Epub 2013 Jun 27. Cancer Radiother. 2013. PMID: 23810304 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

316 results

Search Page

Filters